Anti-PD-1 & CTLA-4 Reference Antibody (Lorigerlimab)
Produktgrößen
100 ug
£ POA
CHB465-100UG
Über dieses Produkt
- SKU:
- CHB465
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- translate.label.attr.clone:
- Lorigerlimab
- Klonalität:
- Recombinant Monoclonal
- Weitere Details:
- Anti-PD-1 & CTLA-4 Reference Antibody (Lorigerlimab) (CHB465) is expressed from CHO, with a configuration of DART. The heavy chain type is huIgG1-scFv. It has a predicted MW of 279.68 kDa.
- Immunogen:
- PD-1 & CTLA-4
- Isotyp:
- IgG
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- Please refer to datasheet
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:CHB465